9. The History and Future of Lipids...

9. The History and Future of Lipids — the Building Blocks of the Structure and Function of Living Cells and their Role in Drug Delivery Chair: PD Dr. Peter van Hoogevest, Consultant at PHARMANOVATION and Member of the Scientific Advisory Council, Phospholipid Research Center, and Heidelberg (DE) About: Lipid nanoparticles (LNPs) and liposomes are the most advanced drug delivery system. Regulatory authorities have approved numerous LNP and liposomal drugs over the past decades, and we now have a wide variety of lipid-based nanoparticle formulations for multiple applications. In nanomedicine, LNPs and liposomes are probably the best choices for cargo transport because they fulfill many of the necessary aspects of a drug delivery vehicle. Frankly, without lipids, there would be no light-speed and efficient COVID-19 vaccine. This session will elucidate the evolution of phospholipids and discuss the future potential for lipid-based drug delivery in therapy. • The Phospholipid Research Center — Current Research in Phospholipids and their Use in Drug Delivery PD Dr. habil. Simon Drescher, Managing Director, Phospholipid Research Center, Heidelberg (DE) • Why did Father Universe and Mother Nature beget Lipids? Prof. em. Dr. Alfred Fahr, Institute of Pharmacy, Friedrich-Schiller-University Jena, (DE) • Liposomes and LNPs: the Best Nanotechnology? PD Dr. Peter van Hoogevest, Consultant at PHARMANOVATION and Member of the Scientific Advisory Council, Phospholipid Research Center, Heidelberg (DE) • Drug Co-encapsulation in Lipid Nanoparticles for a Multimodality Approach to Cancer Therapy Prof. Dr. med. Alberto A. Gabizon, Hebrew University ‐ School of Medicine ‐ Shaare Zedek MC Oncology; Institute, Jerusalem (IL)